Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. United States
  4. Nyse
  5. QIAGEN N.V.
  6. News
  7. Summary
    QGEN   NL0012169213

QIAGEN N.V.

(QGEN)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

QIAGEN NV : DZ Bank reaffirms its Neutral rating

09/20/2021 | 10:37am EDT

DZ Bank confirms his opinion on the stock and remains Neutral.


© MarketScreener with dpa-AFX Analyser 2021
All news about QIAGEN N.V.
10/22QIAGEN N : Completes Transfer of Precision Medicine Research Operations to Manchester
MT
10/22QIAGEN N : Strengthens UK Footprint With Move to New Manchester Facilities
BU
10/20QIAGEN N.V. : to Release Results for Q3 2021 and First Nine Months of 2021
BU
10/19QIAGEN N : Launches QIAreach Quanti-FERON-TB for TB Testing in High Burden Regions
MT
10/19QIAGEN N : Launches Novel QIAreach QuantiFERON-TB Tuberculosis Test for High-Burden Region..
BU
10/19QIAGEN N.V. Launches Novel QIAreach QuantiFERON-TB Tuberculosis Test for High-Burden Re..
CI
10/19QIAGEN N.V. : Release of a capital market information
EQ
10/19QIAGEN N.V. : Release of a capital market information
DJ
10/14QIAGEN N : Redburn Starts Qiagen NV at Buy
MT
10/12QIAGEN N.V. : Release of a capital market information
DJ
More news
Analyst Recommendations on QIAGEN N.V.
More recommendations
Financials (USD)
Sales 2021 2 157 M - -
Net income 2021 449 M - -
Net Debt 2021 942 M - -
P/E ratio 2021 27,5x
Yield 2021 -
Capitalization 12 245 M 12 245 M -
EV / Sales 2021 6,11x
EV / Sales 2022 6,27x
Nbr of Employees 5 900
Free-Float 98,3%
Chart QIAGEN N.V.
Duration : Period :
QIAGEN N.V. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends QIAGEN N.V.
Short TermMid-TermLong Term
TrendsNeutralNeutralNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 14
Last Close Price 53,99 $
Average target price 55,96 $
Spread / Average Target 3,65%
EPS Revisions
Managers and Directors
Thierry Bernard Chief Executive Officer & Managing Director
Roland Sackers Chief Financial Officer & Managing Director
Lawrence A. Rosen Chairman-Supervisory Board
Barthold Piening Senior Vice President & Head-Global Operations
Metin Colpan Independent Member-Supervisory Board
Sector and Competitors
1st jan.Capi. (M$)
QIAGEN N.V.2.16%12 245
MODERNA, INC.212.57%131 807
LONZA GROUP AG32.74%61 177
IQVIA HOLDINGS INC.43.38%49 092
SEAGEN INC.-2.12%31 189
CELLTRION, INC.-38.86%25 455